Our study findings indicate that initiation and titration of U-500R leads to improved patient perception, improved impact of diabetes treatment on functioning and well-being, and less injection site discomfort following use of high-dose, high-volume U-100 insulins in severely insulin-resistant patients with type 2 diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.